{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:46Z","timestamp":1772165746205,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prognosis of advanced oral cancer remains dismal. While multimodal therapy is beneficial, maintaining the quality of life of long-term survivors is important. Therefore, risk-adapted treatment regimens need to be designed. We herein investigated whether pathological responses in oral cancer patients treated with preoperative chemoradiotherapy predict locoregional recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed the data of 51 oral cancer patients who received preoperative radiotherapy and concurrent pepleomycin, followed by curative surgery at our institution between January 2009 and June 2018. Each patient received preoperative external beam irradiation to the primary tumor and lymphatics (2\u2009Gy per day for approximately 3\u2009weeks) concurrent with pepleomycin (2.5\u2009mg\/day). Surgery was performed approximately 3\u20134\u2009weeks after the completion of preoperative chemoradiotherapy. Pathological responses were defined based on the grading system of Oboshi and Shimosato.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eight, 22, 16, and 5 patients had Oboshi and Shimosato grades 2a, 2b, 3, and 4, respectively. Favorable pathological responses (grades 3 and 4) were observed in 41.2% of patients (21 out of 51 patients). The pathological response and number of pathological lymph node metastases were identified as significant prognostic factors for locoregional control in the univariate analysis. Three-year locoregional control rates were 100 and 56.6% in patients with favorable and unfavorable pathological responses, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study demonstrated that pathological tumor responses to preoperative chemoradiotherapy are a useful predictive factor for locoregional control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07707-2","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T14:03:19Z","timestamp":1607608999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathological responses to low-dose irradiation and Pepleomycin in Oral squamous cell carcinoma are predictive of Locoregional control"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-487X","authenticated-orcid":false,"given":"Tomohiro","family":"Katagiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Moriki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"7707_CR1","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Head and Neck Cancers, Version 1. 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed 12 Feb 2020."},{"issue":"2","key":"7707_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jcms.2007.06.007","volume":"36","author":"C Klug","year":"2008","unstructured":"Klug C, Berzaczy D, Voracek M, Millesi W. Preoperative chemoradiotherapy in the management of oral cancer: a review. J Craniomaxillofac Surg. 2008;36(2):75\u201388. https:\/\/doi.org\/10.1016\/j.jcms.2007.06.007.","journal-title":"J Craniomaxillofac Surg"},{"key":"7707_CR3","unstructured":"Tumors. JSFO, Surgeons. JSoOaM (2013) Evidence-based Oral Cancer treatment guideline. Kanehara Shuppan, Tokyo."},{"issue":"10","key":"7707_CR4","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.oraloncology.2015.07.002","volume":"51","author":"S Rathod","year":"2015","unstructured":"Rathod S, Livergant J, Klein J, Witterick I, Ringash J. A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment. Oral Oncol. 2015;51(10):888\u2013900. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.07.002.","journal-title":"Oral Oncol"},{"key":"7707_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/1471-2407-12-567","volume":"12","author":"TF Lee","year":"2012","unstructured":"Lee TF, Chao PJ, Wang HY, Hsu HC, Chang P, Chen WC. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments. BMC Cancer. 2012;12:567. https:\/\/doi.org\/10.1186\/1471-2407-12-567.","journal-title":"BMC Cancer"},{"issue":"2","key":"7707_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijrobp.2008.11.041","volume":"75","author":"P Dirix","year":"2009","unstructured":"Dirix P, Abbeel S, Vanstraelen B, Hermans R, Nuyts S. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2009;75(2):385\u201392. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.11.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"7707_CR7","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/lary.27191","volume":"128","author":"E Katsoulakis","year":"2018","unstructured":"Katsoulakis E, Leeman JE, Lok BH, Shi W, Zhang Z, Tsai JC, McBride SM, Sherman EJ, Cohen M, Wong R, Ganly I, Lee NY, Riaz N. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery. Laryngoscope. 2018;128(11):2539\u201345. https:\/\/doi.org\/10.1002\/lary.27191.","journal-title":"Laryngoscope"},{"issue":"4 Pt 1","key":"7707_CR8","first-page":"775","volume":"16","author":"H Kanazawa","year":"1989","unstructured":"Kanazawa H, Takahashi K, Hanazawa Y, Uchiyama S, Takahara T, Takahara M, Muto M, Kinehara M, Sato K. Continuous subcutaneous infusion of peplomycin in oral squamous carcinoma. Gan To Kagaku Ryoho. 1989;16(4 Pt 1):775\u201380.","journal-title":"Gan To Kagaku Ryoho"},{"key":"7707_CR9","first-page":"19","volume":"1","author":"Y Shimosato","year":"1971","unstructured":"Shimosato Y, Oboshii S, Baba K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol. 1971;1:19\u201335.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"7707_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1067\/moe.2001.112686","volume":"91","author":"T Kirita","year":"2001","unstructured":"Kirita T, Shimooka H, Yamanaka Y, Tatebayashi S, Yamamoto K, Nishimine M, Sugimura M. Prognostic value of response to preoperative chemoradiotherapy and residual tumor grades in tongue carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(3):293\u2013300. https:\/\/doi.org\/10.1067\/moe.2001.112686.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"7707_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijom.2004.04.004","volume":"34","author":"C Klug","year":"2005","unstructured":"Klug C, Wutzl A, Kermer C, Ploder O, Sulzbacher I, Selzer E, Voracek M, Oeckher M, Ewers R, Millesi W. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor. Int J Oral Maxillofac Surg. 2005;34(3):262\u20137. https:\/\/doi.org\/10.1016\/j.ijom.2004.04.004.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"7707_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/02841860410018430","volume":"43","author":"FM Fang","year":"2004","unstructured":"Fang FM, Chien CY, Kuo SC, Chiu HC, Wang CJ. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy. Acta Oncol. 2004;43(6):571\u20138. https:\/\/doi.org\/10.1080\/02841860410018430.","journal-title":"Acta Oncol"},{"issue":"1","key":"7707_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.radonc.2007.07.009","volume":"85","author":"PC Levendag","year":"2007","unstructured":"Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJ, Kolkman-Deurloo IK, Prevost JB, Poll J, Schmitz PI, Heijmen BJ. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol. 2007;85(1):64\u201373. https:\/\/doi.org\/10.1016\/j.radonc.2007.07.009.","journal-title":"Radiother Oncol"},{"issue":"2","key":"7707_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2009.07.1708","volume":"78","author":"T Dijkema","year":"2010","unstructured":"Dijkema T, Raaijmakers CP, Ten Haken RK, Roesink JM, Braam PM, Houweling AC, Moerland MA, Eisbruch A, Terhaard CH. Parotid gland function after radiotherapy: the combined Michigan and Utrecht experience. Int J Radiat Oncol Biol Phys. 2010;78(2):449\u201353. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1708.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"7707_CR15","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","volume":"76","author":"JO Deasy","year":"2010","unstructured":"Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S58\u201363. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.090.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"7707_CR16","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1200\/jco.2009.24.6199","volume":"28","author":"FY Feng","year":"2010","unstructured":"Feng FY, Kim HM, Lyden TH, Haxer MJ, Worden FP, Feng M, Moyer JS, Prince ME, Carey TE, Wolf GT, Bradford CR, Chepeha DB, Eisbruch A. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010;28(16):2732\u20138. https:\/\/doi.org\/10.1200\/jco.2009.24.6199.","journal-title":"J Clin Oncol"},{"issue":"2","key":"7707_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s1470-2045(10)70290-4","volume":"12","author":"CM Nutting","year":"2011","unstructured":"Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127\u201336. https:\/\/doi.org\/10.1016\/s1470-2045(10)70290-4.","journal-title":"Lancet Oncol"},{"issue":"2","key":"7707_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semradonc.2018.11.011","volume":"29","author":"M Tam","year":"2019","unstructured":"Tam M, Hu K. Regional radiation therapy for Oropharyngeal Cancer in the HPV era. Semin Radiat Oncol. 2019;29(2):126\u201336. https:\/\/doi.org\/10.1016\/j.semradonc.2018.11.011.","journal-title":"Semin Radiat Oncol"},{"key":"7707_CR19","doi-asserted-by":"publisher","unstructured":"Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T. A review of HPV-related head and neck Cancer. J Clin Med. 2018;7(9). https:\/\/doi.org\/10.3390\/jcm7090241.","DOI":"10.3390\/jcm7090241"},{"issue":"8","key":"7707_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/jop.12416","volume":"45","author":"A Kouketsu","year":"2016","unstructured":"Kouketsu A, Sato I, Abe S, Oikawa M, Shimizu Y, Takahashi T, Kumamoto H. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients. J Oral Pathol Med. 2016;45(8):565\u201372. https:\/\/doi.org\/10.1111\/jop.12416.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"7707_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jcms.2016.02.003","volume":"44","author":"S Blatt","year":"2016","unstructured":"Blatt S, Ziebart T, Kr\u00fcger M, Pabst AM. Diagnosing oral squamous cell carcinoma: how much imaging do we really need? A review of the current literature. J Craniomaxillofac Surg. 2016;44(5):538\u201349. https:\/\/doi.org\/10.1016\/j.jcms.2016.02.003.","journal-title":"J Craniomaxillofac Surg"},{"issue":"5","key":"7707_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.oraloncology.2011.03.009","volume":"47","author":"AJ Fasunla","year":"2011","unstructured":"Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol. 2011;47(5):320\u20134. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.03.009.","journal-title":"Oral Oncol"},{"issue":"7","key":"7707_CR23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamaoto.2017.0012","volume":"143","author":"MT Spiotto","year":"2017","unstructured":"Spiotto MT, Jefferson G, Wenig B, Markiewicz M, Weichselbaum RR, Koshy M. Differences in survival with surgery and postoperative radiotherapy compared with definitive Chemoradiotherapy for Oral cavity Cancer: a National Cancer Database Analysis. JAMA Otolaryngol Head Neck Surg. 2017;143(7):691\u20139. https:\/\/doi.org\/10.1001\/jamaoto.2017.0012.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"7707_CR24","doi-asserted-by":"publisher","unstructured":"Zhong L, Zhang C, Ren G, Guo W, William WN, Sun J, Zhu H, Tu W, Li J, Cai Y, Wang L, Fan X, Wang Z, Hu Y, Ji T, Yang W, Ye W, Li J, He Y, Wang Y, Xu L, Wang B, Kies MS, Lee JJ, Myers JN, Zhang Z (2013) Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31 (6):744\u2013751. doi:https:\/\/doi.org\/10.1200\/jco.2012.43.8820.","DOI":"10.1200\/jco.2012.43.8820"},{"issue":"5","key":"7707_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ncponc0796","volume":"4","author":"L Kleinberg","year":"2007","unstructured":"Kleinberg L, Gibson MK, Forastiere AA. Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization. Nat Clin Pract Oncol. 2007;4(5):282\u201394. https:\/\/doi.org\/10.1038\/ncponc0796.","journal-title":"Nat Clin Pract Oncol"},{"issue":"1","key":"7707_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/s1470-2045(09)70306-7","volume":"11","author":"JS Tobias","year":"2010","unstructured":"Tobias JS, Monson K, Gupta N, Macdougall H, Glaholm J, Hutchison I, Kadalayil L, Hackshaw A. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK head and neck (UKHAN1) trial. Lancet Oncol. 2010;11(1):66\u201374. https:\/\/doi.org\/10.1016\/s1470-2045(09)70306-7.","journal-title":"Lancet Oncol"},{"issue":"4B","key":"7707_CR27","first-page":"2197","volume":"28","author":"Y Liu","year":"2008","unstructured":"Liu Y, Sakagami H, Amano O, Kikuchi H, Nakamura Y, Ishihara M, Kanda Y, Kunii S, Zhang W, Yu G. Tumor-specific cytotoxicity and type of cell death induced by peplomycin in oral squamous cell carcinoma cell lines. Anticancer Res. 2008;28(4B):2197\u2013204.","journal-title":"Anticancer Res"},{"issue":"11","key":"7707_CR28","first-page":"3244","volume":"13","author":"M Urade","year":"1986","unstructured":"Urade M, Sugi M, Igarashi T. Effect of filipin, a polyene antibiotic, on human tumor cell killing in vitro by peplomycin. Gan To Kagaku Ryoho. 1986;13(11):3244\u201350.","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07707-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-07707-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07707-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T14:06:22Z","timestamp":1607609182000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07707-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7707"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07707-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-56335\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-56335\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-56335\/v3","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Institutional Review Board of Shizuoka City Shizuoka Hospital, and written informed consent was waived because of its retrospective design. Approval was registered under local number 20\u201304. The director of Shizuoka City Shizuoka Hospital provided administrative permissions for access to the patient data used in our research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1216"}}